|
Ramos-Molina B, Tovar-Palacio C, Torre-Villalvazo I, Khan MW. Editorial: Unraveling the links between nutrients and metabolic dysfunction-associated liver disease: insights and implications. Front Nutr. 2024 Nov 27;11:1525180. doi: 10.3389/fnut.2024.1525180. eCollection 2024. No abstract available. PubMed PMID: 39668895; PubMed Central PMCID: PMC11635608.
AÑO: 2024; IF: 5.1
|
39668895
|
Ramos-Molina B, Rossell J, Perez-Montes de Oca A, Pardina E, Genua I, Rojo-Lopez MI, Julian MT, Alonso N, Julve J, Mauricio D. Therapeutic implications for sphingolipid metabolism in metabolic dysfunction-associated steatohepatitis. Front Endocrinol (Lausanne). 2024 Jun 19;15:1400961. doi: 10.3389/fendo.2024.1400961. eCollection 2024. PubMed PMID: 38962680; PubMed Central PMCID: PMC11220194.
AÑO: 2024; IF: 4.6
|
|
Ponce Martinez C, Murcia Garcia E, Perez Sanchez H, Milagro FI, Riezu-Boj JI, Ramos Molina B, Gomez Gallego M, Zamora S, Canavate Cutillas R, Hernandez Morante JJ. Effect of Silibinin on Human Pancreatic Lipase Inhibition and Gut Microbiota in Healthy Volunteers: A Randomized Controlled Trial. Int J Mol Sci. 2024 Nov 29;25(23):12853. doi: 10.3390/ijms252312853. PubMed PMID: 39684564; PubMed Central PMCID: PMC11640983.
AÑO: 2024; IF: 4.9
|
|
Nunez-Sanchez MA, Martinez-Sanchez MA, Martinez-Montoro JI, Balaguer-Roman A, Murcia-Garcia E, Fernandez-Ruiz VE, Ferrer-Gomez M, Martinez-Caceres CM, Sledzinski T, Frutos MD, Hernandez-Morante JJ, Fernandez-Garcia JC, Queipo-Ortuno MI, Ruiz-Alcaraz AJ, Mika A, Ramos-Molina B. Lipidomic Analysis Reveals Alterations in Hepatic FA Profile Associated With MASLD Stage in Patients With Obesity. J Clin Endocrinol Metab. 2024 Jun 17;109(7):1781-1792. doi: 10.1210/clinem/dgae028. PubMed PMID: 38217869.
AÑO: 2024; IF: 5.1
|
|
Nunez-Sanchez MA, Martinez-Sanchez MA, Sierra-Cruz M, Lambertos A, Rico-Chazarra S, Oliva-Bolarin A, Balaguer-Roman A, Yuste JE, Martinez CM, Mika A, Frutos MD, Llamoza-Torres CJ, Cordoba-Chacon J, Ramos-Molina B. Increased hepatic putrescine levels as a new potential factor related to the progression of metabolic dysfunction-associated steatotic liver disease. J Pathol. 2024 Sep;264(1):101-111. doi: 10.1002/path.6330. Epub 2024 Jul 18. PubMed PMID: 39022853; PubMed Central PMCID: PMC11300153.
AÑO: 2024; IF: 5.2
|